You just read:

Following Congressional Hearing Investigating Mylan and Epi-Pen, Imprimis Pharmaceuticals Founder and CEO Publishes Drug Pricing Monograph

News provided by

Imprimis Pharmaceuticals, Inc.

Sep 22, 2016, 08:30 ET